CAPTRUST Financial Advisors’s Cantel Medical CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-294
| Closed | -$23K | – | 4806 |
|
|
2021
Q1 | $23K | Buy |
294
+219
| +292% | +$17.1K | ﹤0.01% | 2925 |
|
|
2020
Q4 | $6K | Buy |
75
+35
| +88% | +$2.05K | ﹤0.01% | 2807 |
|
|
2020
Q3 | $2K | Buy |
+40
| New | +$1.97K | ﹤0.01% | 2840 |
|
|
2019
Q4 | – | Sell |
-456
| Closed | -$34K | – | 1983 |
|
|
2019
Q3 | $34K | Sell |
456
-10
| -2% | -$848 | ﹤0.01% | 1130 |
|
|
2019
Q2 | $38K | Sell |
466
-18
| -4% | -$1.27K | ﹤0.01% | 1076 |
|
|
2019
Q1 | $32K | Buy |
484
+183
| +61% | +$13.9K | ﹤0.01% | 1028 |
|
|
2018
Q4 | $22K | Buy |
301
+71
| +31% | +$5.86K | ﹤0.01% | 999 |
|
|
2018
Q3 | $21K | Sell |
230
-80
| -26% | -$7.62K | ﹤0.01% | 991 |
|
|
2018
Q2 | $30K | Buy |
310
+116
| +60% | +$13K | ﹤0.01% | 836 |
|
|
2018
Q1 | $21K | Sell |
194
-56
| -22% | -$6.28K | ﹤0.01% | 826 |
|
|
2017
Q4 | $26K | Buy |
+250
| New | +$24.9K | ﹤0.01% | 726 |
|
CAPTRUST Financial Advisors's CMD Position: Q2 2021 in Review
CAPTRUST Financial Advisors sold out of Cantel Medical (CMD) in Q2 2021, closing a stake of 294 shares — an estimated $23K sold.
CAPTRUST Financial Advisors first reported a position in CMD in Q4 2017 and held it in 11 quarters. The position peaked at $38K in Q2 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- CAPTRUST Financial Advisors reported no remaining Cantel Medical position as of Q2 2021 after selling out during the quarter.
- CAPTRUST Financial Advisors sold 294 Cantel Medical shares in Q2 2021, an estimated $23K.
- CAPTRUST Financial Advisors first reported a position in Cantel Medical in Q4 2017 and held it in 11 quarters.
- CAPTRUST Financial Advisors's Cantel Medical position peaked at $38K in Q2 2019.
- 0 funds tracked by Wall St. Rank held Cantel Medical as of Q2 2021.
Based on CAPTRUST Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.